Novo buys majority stake in BBI Group at $562m-plus enterprise value

Novo Holdings’ investment in BBI is part of its Principal Investments strategy targeting investments in well-established life science companies with leading positions in attractive market segments and strong underlying growth drivers.

DealsHealthcareBriefs